Open in App
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd.
NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is a manufacturer and developer of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs). The company focuses on chronic therapeutic areas, including cardiovascular dise...

Read More
Ask AI about Alivus Life Sciences
1417.90 -25.80 (-1.79%)
New 52W High in past week
572.7K
NSE+BSE Volume
High volume today

NSE 02 Sep, 2026 3:53 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Alivus Life Sciences last dividend of ₹5.000 per share was given on 01 Sep 2026 See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
60.8 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
1,432
1Yr Price target upside is 1%
4 analysts

26

S

9

W

3

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView
Switch to

Alivus Life Sciences Live Price Chart

Custom


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
134 Votes:
Buy 75.37%
Sell 11.94%
Hold 12.69%
BUY
SELL
HOLD
Ask AI
×